These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9072005)

  • 1. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
    Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
    J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
    Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome.
    Kumar-Singh S; Jacobs W; Dhaene K; Weyn B; Bogers J; Weyler J; Van Marck E
    J Pathol; 1998 Nov; 186(3):300-5. PubMed ID: 10211120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma.
    Lindholm PM; Soini Y; Myllärniemi M; Knuutila S; Heikinheimo M; Kinnula VL; Salmenkivi K
    J Clin Pathol; 2009 Apr; 62(4):339-44. PubMed ID: 19060016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression.
    Kumar-Singh S; Weyler J; Martin MJ; Vermeulen PB; Van Marck E
    J Pathol; 1999 Sep; 189(1):72-8. PubMed ID: 10451491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules.
    Lee TC; Zhang Y; Aston C; Hintz R; Jagirdar J; Perle MA; Burt M; Rom WN
    Cancer Res; 1993 Jun; 53(12):2858-64. PubMed ID: 7684950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma.
    Enomoto Y; Kasai T; Takeda M; Takano M; Morita K; Kadota E; Iizuka N; Maruyama H; Haratake J; Kojima Y; Ikeda N; Nonomura A
    Pathol Int; 2012 Apr; 62(4):226-31. PubMed ID: 22449226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor.
    Menke AL; Shvarts A; Riteco N; van Ham RC; van der Eb AJ; Jochemsen AG
    Cancer Res; 1997 Apr; 57(7):1353-63. PubMed ID: 9102224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
    Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
    Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
    Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
    Strizzi L; Catalano A; Vianale G; Orecchia S; Casalini A; Tassi G; Puntoni R; Mutti L; Procopio A
    J Pathol; 2001 Apr; 193(4):468-75. PubMed ID: 11276005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes.
    Hoang CD; Zhang X; Scott PD; Guillaume TJ; Maddaus MA; Yee D; Kratzke RA
    Cancer Res; 2004 Oct; 64(20):7479-85. PubMed ID: 15492273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a tumor-specific methylation site in the Wilms tumor suppressor gene.
    Kleymenova EV; Yuan X; LaBate ME; Walker CL
    Oncogene; 1998 Feb; 16(6):713-20. PubMed ID: 9488035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of WT1 target gene expression in stably transfected cell lines.
    Thäte C; Englert C; Gessler M
    Oncogene; 1998 Sep; 17(10):1287-94. PubMed ID: 9771972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.
    Rena O; Boldorini LR; Gaudino E; Casadio C
    J Surg Oncol; 2011 Nov; 104(6):701-5. PubMed ID: 21437912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
    Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
    Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status.
    Kobayashi M; Takeuchi T; Ohtsuki Y
    Anticancer Res; 2008; 28(1A):197-208. PubMed ID: 18383846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.
    Filho AL; Baltazar F; Bedrossian C; Michael C; Schmitt FC
    Diagn Cytopathol; 2007 Dec; 35(12):786-91. PubMed ID: 18008346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.
    Park S; Schalling M; Bernard A; Maheswaran S; Shipley GC; Roberts D; Fletcher J; Shipman R; Rheinwald J; Demetri G
    Nat Genet; 1993 Aug; 4(4):415-20. PubMed ID: 8401592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.